Biologic Roles of Cytokines in Tissue Fibrosis and Vascular Damage in Systemic Sclerosis(<Special Issue>Pathogenesis of the Collagen Disease and Extracellular Matrix Reseaches)
スポンサーリンク
概要
- 論文の詳細を見る
Systemic sclerosis (SSc) is characterized by a complex interaction of immunologic abnormalities, including autoantibody production, T-cell activation, vascular damage, and increased collagen production by fibroblasts. Tissue fibrosis, resulting from the excessive accumulation of matrix proteins, is the particular hallmark of SSc. An understanding of the pathophysiology of fibroblast activation has been a subject of studies involving the pathways that lead to tissue fibrosis in SSc. In particular, cytokine or growth factor signaling was shown to modulate key regulatory pathways that are involved in synthesis of matrix components by fibroblasts. Additionally, chemical mediators contributed to injury of endothelial cells in SSc. This article discusses the biologic functions of cytokines that contribute to fibrosis and vascular damage in SSc.
- 日本結合組織学会の論文
- 2004-12-25
著者
-
Kawaguchi Yasushi
Institute Of Rheumatology Tokyo Women's Medical University
-
川口 鎮司
Institute of Rheumatology, Tokyo Women's Medical University
関連論文
- Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations
- A functional SNP in the NKX2.5-binding site of ITPR3 promoter is associated with susceptibility to systemic lupus erythematosus in Japanese population
- Identification of a significant association of a single nucleotide polymorphism in TNXB with systemic lupus erythematosus in a Japanese population
- Classification of systemic sclerosis in the Japanese population based on rapid progression of skin thickening
- Increased IL-15 production of muscle cells in polymyositis and dermatomyositis
- Progressive Interstitial Renal Fibrosis Due to Chinese Herbs in a Patient with Calcinosis Raynaud Esophageal Sclerodactyly Telangiectasia (CREST) Syndrome
- Acceptability and usefulness of mizoribine in the management of rheumatoid arthritis in methotrexate-refractory patients and elderly patients, based on analysis of data from a large-scale observational cohort study
- Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis/polymyositis
- Single nucleotide polymorphisms of CD244 gene predispose to renal and neuropsychiatric manifestations with systemic lupus erythematosus
- Biologic Roles of Cytokines in Tissue Fibrosis and Vascular Damage in Systemic Sclerosis(Pathogenesis of the Collagen Disease and Extracellular Matrix Reseaches)
- Polymyalgia Rheumatica and Type 2 Diabetes Mellitus Complicated with Electromyographic Abnormalities That Responded Well to Corticosteroid Therapy
- Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis
- Interleukin-18 promoter polymorphisms in Japanese patients with rheumatoid arthritis : protective effect of the T allele and T/T genotype at rs360722
- Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis : 4-year follow-up
- Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseases
- Methemoglobinemia Induced by Trimethoprim-Sulfamethoxazole in a Patient with Systemic Lupus Erythematosus
- Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility in Japanese rheumatoid arthritis patients
- Serum antibodies against the 70k polypeptides of the U1 ribonucleoprotein complex are associated with psychiatric syndromes in systemic lupus erythematosus : a retrospective study
- A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation : an unusual phenotype of Blau syndrome/early-onset sarcoidosis?